Sectors

New Hope Group was among the participants in the dental clinic franchise owner's series B round, which lifted its overall funding past $200m.

Samsung, NTT Docomo and Huya helped the livestreaming technology provider close a round that took its overall funding to $166m.

The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.

Kaiser Permanente co-led the medical data software provider's latest round, pushing its total funding past the $170m mark.

WUSTL spinout Wugen has collected $172m in a series B round to progress its pipeline targeting several cancer indications.

Johnson & Johnson, Novartis and Takeda returned to back the cancer and inflammatory drug developer and were joined by investors including AbbVie, Alphabet and Bristol Myers Squibb.

Target Global led the RGA-backed gamified life insurance platform’s series B round, which valued it at almost $350m.

The BCC and SIG-backed news aggregator was valued at about $550m in a round led by technology investment firm Vy Capital.

Softbank enabled the cybersecurity software provider Cybereason to secure crossover financing at a valuation likely to have exceeded $3bn. This year seems set to be a record one for the broader corporate-backed cybersecurity space, with valuations spiking up.

Greenhouse gas monitor GHGSat boosted a Schlumberger-backed round to $45m while Toyota’s Woven Planet subsidiary is buying spatial intelligence software developer Carmera.

The gene editing technology developer is the latest spinout emerging out of the lab of David Liu at Broad Institute.